Amplification and sequence analysis of partial bacterial 16S ribosomal RNA gene in gallbladder bile from patients with primary biliary cirrhosis

Journal of Hepatology

Volumn 33, Issue 1, 2000, Pages 9-18

  Hiramatsu, Katsushi ^a,c   Harada, Kenichi ^b   Tsuneyama, Koichi ^b   Sasaki, Motoko ^a   Fujita, Shinichi ^b   Hashimoto, Takuma ^b   Kaneko, Shuichi ^b   Kobayashi, Kenichi ^c   Nakanuma, Yasuni ^a  

^a Yasuni Nakanuma   (Japan)

^b Department of Laboratory Medicine ^*

^c KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Bacterial 16S ribosomal RNA gene; Bacterial universal primer; Bile; Polymerase chain reaction; Primary biliary cirrhosis

Indexed keywords

BACTERIAL RNA; RNA 16S;

ADULT; ARTICLE; BACTERIUM IDENTIFICATION; BILE; CLINICAL ARTICLE; FEMALE; GALLBLADDER; GENE AMPLIFICATION; GENE SEQUENCE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL;

EID: 0033916878     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80153-1     Document Type: Article

References (56)

1. Nakanuma Y, Yasoshima M, Tsuneyama K, Harada K. Histopathology of primary biliary cirrhosis with emphasis on expression of adhesion molecules. Semin Liver Dis. 17:1997;35-47.
2. Scheuer PJ. Liver Biopsy Interpretation, 3rd edn. 1980;Baillière Tindall, London.
3. Patrick SC, Leung PS, Coppel RL, Ansari A, Munoz S, Gershwin ME. Antimitochondrial antibodies in primary biliary cirrhosis. Semin Liver Dis. 17:1997;61-69.
4. Bach N, Schaffner F. Familial primary biliary cirrhosis. J Hepatol. 20:1994;698-701.
5. Hamlyn AN, Macklon AF, James O. Primary biliary cirrhosis: geographical clustering and symptomatic onset seasonality. Gut. 24:1983;940-945.
6. Boddinghaus B, Rogall T, Flohr T, Blocker H, Bottger EC. Detection and identification of mycobacteria by amplification of rRNA. J Clin Microbiol. 28:1990;1751-1759.
7. O'Donohue J, Fidler H, Garcia-Barcelo M, Nouri-Aria K, Williams R, McFadden J. Mycobacterial DNA not detected in liver sections from patients with primary biliary cirrhosis. J Hepatol. 28:1998;433-438.
8. Vilagut L, Vila J, Vinas O, Pares A, Gines A, Jimenez de Anta MT, et al. Cross-reactivity of anti-Mycobacterium gordonae antibodies with the major mitochondrial autoantigens in primary biliary cirrhosis. J Hepatol. 21:1994;673-677.
9. Butler P, Valle F, Hamilton-Miller JM, Brumfitt W, Baum H, Burroughs AK. M2 mitochondrial antibodies and urinary rough mutant bacteria in patients with primary biliary cirrhosis and in patients with recurrent bacteriuria. J Hepatol. 17:1993;408-414.
10. Nagura H, Smith PD, Nakane PK, Brown WR. IgA in human bile and liver. J Immunol. 126:1981;587-595.
11. Sugiura H, Nakanuma Y. Secretory component and immunoglobulins in the intrahepatic biliary tree and peribiliary gland in normal livers and hepatolithiasis. Gastroenterol Jpn. 24:1989;308-314.
12. Sung JY, Costerton JW, Shaffer EA. Defense system in the biliary tract against bacterial infection. Dig Dis Sci. 37:1992;689-696.
13. Sung JY, Shaffer EA, Olson ME, Leung JW, Lam K, Costerton JW. Bacterial invasion of the biliary system by way of the portalvenous system. Hepatology. 14:1991;313-317.
14. Nakanuma Y, Hoso M, Sanzen T, Sasaki M. Microstructure and development of the normal and pathologic biliary tract in humans, including blood supply. Microsc Res Tech. 38:1997;552-570.
15. Hopf U, Moller B, Stemerowicz R, Lobeck H, Rodloff A, Freudenberg M, et al. Relation between Escherichia coli R(rough)-forms in gut, lipid A in liver, and primary biliary cirrhosis. Lancet. ii:1989;1419-1422.
16. Csendes A, Burdiles P, Maluenda F, Diaz JC, Csendes P, Mitru N. Simultaneous bacteriologic assessment of bile from gallbladder and common bile duct in control subjects and patients with gallstones and common duct stones. Arch Surg. 131:1996;389-394.
17. Tabata M, Nakayama F. Bacteria and gallstones. Etiological significance. Dig Dis Sci. 26:1981;218-224.
18. Olsson R, Bjornsson E, Backman L, Friman S, Hockerstedt K, Kaijser B, et al. Bile duct bacterial isolates in primary sclerosing cholangitis: a study of explanted livers. J Hepatol. 28:1998;426-432.
19. Sasatomi K, Noguchi K, Sakisaka S, Sata M, Tanikawa K. Abnormal accumulation of endotoxin in biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis. J Hepatol. 29:1998;409-416.
20. Tompkins LS. The use of molecular methods in infectious diseases. N Engl J Med. 327:1992;1290-1297.
21. Dauga C, Miras I, Grimont PA. Strategy for detection and identification of bacteria based on 16S rRNA genes in suspected cases of Whipple's disease. J Med Microbiol. 46:1997;340-347.
22. Jaulhac B, Nicolini P, Piemont Y, Monteil H. Detection of Borrelia burgdorferi in cerebrospinal fluid of patients with Lyme borreliosis. [letter] N Engl J Med. 324:1991;1440.
23. Relman DA, Schmidt TM, MacDermott RP, Falkow S. Identification of the uncultured bacillus of Whipple's disease. N Engl J Med. 327:1992;293-301.
24. Saboor SA, Johnson NM, McFadden J. Detection of mycobacterial DNA in sarcoidosis and tuberculosis with polymerase chain reaction. Lancet. 339:1992;1012-1015.
25. Gutell RR, Weiser B, Woese CR, Noller HF. Comparative anatomy of 16-S-like ribosomal RNA. Prog Nucleic Acid Res Mol Biol. 32:1985;155-216.
26. Relman DA. Universal bacterial 16s rDNA amplification and sequencing. Persing DH, Smith TF, Tenover FC, White TJ. Diagnostic Molecular Microbiology. 1993;489-495 ASM Press, Washington, D.C.
27. Woese CR. Bacterial evolution. Microbiol Rev. 51:1987;221-271.
28. Greisen K, Loeffelholz M, Purohit A, Leong D. PCR primers and probes for the 16S rRNA gene of most species of pathogenic bacteria, including bacteria found in cerebrospinal fluid. J Clin Microbiol. 32:1994;335-351.
29. Wilson KH, Blitchington RB, Greene RC. Amplification of bacterial 16S ribosomal DNA with polymerase chain reaction. J Clin Microbiol. 28:1990;1942-1946.
30. Steinman CR, Muralidhar B, Nuovo GJ, Rumore PM, Yu D, Mukai M. Domain-directed polymerase chain reaction capable of distinguishing bacterial from host DNA at the single-cell level: characterization of a systematic method to investigate putative bacterial infection in idiopathic disease. Anal Biochem. 244:1997;328-339.
31. Weisburg WG, Barns SM, Pelletier DA, Lane DJ. 16S ribosomal DNA amplification for phylogenetic study. J Bacteriol. 173:1991;697-703.
32. Oyaizu H, Saitou N. [Ribosomal RNA sequencing with reverse transcriptase: its application to the phylogenetic study of cells]. Seikagaku. 61:1989;693-698.
33. Rand KH, Houck H. Taq polymerase contains bacterial DNA of unknown origin. Mol Cell Probes. 4:1990;445-450.
34. Schmidt TM, Pace B, Pace NR. Detection of DNA contamination in Taq polymerase. Biotechniques. 11:1991;176-177.
35. Broome U, Olsson R, Loof L, Bodemar G, Hultcrantz R, Danielsson A, et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut. 38:1996;610-615.
36. Farrant JM, Hayllar KM, Wilkinson ML, Karani J, Portmann BC, Westaby D, et al. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology. 100:1991;1710-1717.
37. Wiesner RH, Grambsch PM, Dickson ER, Ludwig J, MacCarty RL, et al. Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology. 10:1989;430-436.
38. Takikawa H, Manabe T. Primary sclerosing cholangitis in Japan - analysis of 192 cases. J Gastroenterol. 32:1997;134-137.
39. Carratelli CR, Nuzzo I, Bentivoglio C, Galdiero M. CD11a/CD18 and CD11b/18 modulation by lipoteichoic acid, N-acetyl-muramyl-alpha-alanyl-D-isoglutamine, muramic acid and protein A from Staphylococcus aureus. FEMS Immunol Med Microbiol. 16:1996;309-315.
40. Danforth JM, Strieter RM, Kunkel SL, Arenberg DA, VanOtteren GM, Standiford TJ. Macrophage inflammatory protein-1 alpha expression in vivo and in vitro: the role of lipoteichoic acid. Clin Immunol Immunopathol. 74:1995;77-83.
41. Dunne DW, Resnick D, Greenberg J, Krieger M, Joiner KA. The type I macrophage scavenger receptor binds to gram-positive bacteria and recognizes lipoteichoic acid. Proc Natl Acad Sci USA. 91:1994;1863-1867.
42. Standiford TJ, Arenberg DA, Danforth JM, Kunkel SL, VanOtteren GM, Strieter RM. Lipoteichoic acid induces secretion of interleukin-8 from human blood monocytes: a cellular and molecular analysis. Infect Immun. 62:1994;119-125.
43. Nakanuma Y, Kono N, Ohta G, Kato Y, Kobayashi K. Ultrastructural changes of bile duct epithelium in primary biliary cirrhosis in relation to progression of bile duct loss. Virchows Arch A Pathol Anat Histopathol. 398:1982;149-161.
44. Sakisaka S, Koga H, Sasatomi K, Mimura Y, Kawaguchi T, Tanikawa K. Biliary secretion of endotoxin and pathogenesis of primary biliary cirrhosis. Yale J Biol Med. 70:1997;403-408.
45. Tsuneyama K, Yasoshima M, Harada K, Hiramatsu K, Gershwin ME, Nakanuma Y. Increased CD1d expression on small bile duct epithelium and epithelioid granuloma in primary biliary cirrhosis. Hepatology. 28:1998;620-623.
46. Schwartz DA, Quinn TJ, Thorne PS, Sayeed S, Yi AK, Krieg AM. CpG motifs in bacterial DNA cause inflammation in the lower respiratory tract. J Clin Invest. 100:1997;68-73.
47. Yasoshima M, Kono N, Sugawara H, Katayanagi K, Harada K, Nakanuma Y. Increased expression of interleukin-6 and tumor necrosis factor-alpha in pathologic biliary epithelial cells: in situ and culture study. Lab Invest. 78:1998;89-100.
48. Flannery GR, Burroughs AK, Butler P, Chelliah J, Hamilton-Miller J, Brumfitt W, et al. Antimitochondrial antibodies in primary biliary cirrhosis recognize both specific peptides and shared epitopes of the M2 family of antigens. Hepatology. 10:1989;370-374.
49. Snoep JL, Westphal AH, Benen JA, Teixeira de Mattos MJ, Neijssel OM, de Kok A. Isolation and characterisation of the pyruvate dehydrogenase complex of anaerobically grown Enterococcus faecalis NCTC 775. Eur J Biochem. 203:1992;245-250.
50. Wallbrandt P, Tegman V, Jonsson BH, Wieslander A. Identification and analysis of the genes coding for the putative pyruvate dehydrogenase enzyme complex in Acholeplasma laidlawii. J Bacteriol. 174:1992;1388-1396.
51. Hemila H. Lipoamide dehydrogenase of Staphylococcus aureus: nucleotide sequence and sequence analysis. Biochim Biophys Acta. 1129:1991;119-123.
52. Mollick JA, Miller GG, Musser JM, Cook RG, Grossman D, Rich RR. A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C. J Clin Invest. 92:1993;710-719.
53. Norrby-Teglund A, Newton D, Kotb M, Holm SE, Norgren M. Superantigenic properties of the group A streptococcal exotoxin SpeF (MF). Infect Immun. 62:1994;5227-5233.
54. Uchiyama T, Yan XJ, Imanishi K, Yagi J. Bacterial superantigens - mechanism of T cell activation by the superantigens and their role in the pathogenesis of infectious diseases. Microbiol Immunol. 38:1994;245-256.
55. Watanabe-Ohnishi R, Aelion J, LeGros L, Tomai MA, Sokurenko EV, Newton D, et al. Characterization of unique human TCR V beta specificities for a family of streptococcal superantigens represented by rheumatogenic serotypes of M protein. J Immunol. 152:1994;2066-2073.
56. Martino R, Martinez C, Pericas R, Salazar R, Sola C, Brunet S, et al. Bacteremia due to glucose non-fermenting gram-negative bacilli in patients with hematological neoplasias and solid tumors. Eur J Clin Microbiol Infect Dis. 15:1996;610-615.